Moreover, in the FLIRT trial, 63 patients with biopsy-proven NASH and increased ALT, of whom 20 were diabetic, were randomized to receive either rosiglitazone or placebo for 1 year
However, they are not a replacement for other necessary treatments
The post classifies retatrutide as investigational, describing it as a newer triple GIP, GLP-1, and glucagon receptor agonist that remains primarily in clinical development
Sitagliptin in Combination with Metformin Immediate-Release and Insulin In a 24-week placebo-controlled study of sitagliptin 100 mg as add-on therapy in patients with type 2 diabetes inadequately controlled on metformin immediate-release and insulin (sitagliptin, N=229
Within You cannot have a vitamin B12 injection if: You are sensitive to any of the excipients, which are - acetic acid, sodium chloride, sodium hydroxide, and water for injections
pubmed.ncbi.nlm.nih.gov/25109781